Ming-Han Chen Selected Research

Ming-Han Chen Research Topics

Disease

11	Inflammation (Inflammations) 04/2024 - 07/2012
10	Neoplasms (Cancer) 01/2024 - 01/2013
7	Infections 12/2023 - 04/2011
7	Rheumatoid Arthritis 01/2022 - 01/2017
5	Autoimmune Diseases (Autoimmune Disease) 04/2024 - 01/2019
5	Ankylosing Spondylitis 01/2024 - 07/2012
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2023 - 01/2019
5	Cholangiocarcinoma 07/2018 - 01/2013
4	Arthritis (Polyarthritis) 01/2022 - 01/2009
3	Asthma (Bronchial Asthma) 11/2023 - 01/2017
3	Chronic Renal Insufficiency 10/2023 - 12/2018
3	Melanoma (Melanoma, Malignant) 06/2022 - 01/2020
2	COVID-19 12/2023 - 01/2023
2	Sarcoma (Soft Tissue Sarcoma) 06/2022 - 01/2013
2	Neoplasm Metastasis (Metastasis) 06/2022 - 08/2016
2	Hypersensitivity (Allergy) 01/2022 - 07/2020
2	Immunoglobulin G4-Related Disease 01/2022 - 07/2020
2	Hepatitis 01/2022 - 01/2021
2	Nephritis 01/2022 - 01/2021
2	Hepatitis B 11/2021 - 08/2021
2	Rheumatic Diseases (Rheumatism) 11/2021 - 05/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 11/2011
1	Connective Tissue Diseases (Connective Tissue Disease) 12/2023
1	Systemic Vasculitis 12/2023
1	Microscopic Polyangiitis 12/2023
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 12/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2023
1	Atopic Dermatitis (Atopic Eczema) 11/2023
1	Leukocytosis (Pleocytosis) 01/2023
1	Hypertrophy 01/2023
1	Hypertension (High Blood Pressure) 11/2022
1	Sepsis (Septicemia) 11/2022
1	Bacterial Pneumonia 11/2022
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Disease Progression 06/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2022
1	Eosinophilia 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Osteoporotic Fractures 01/2022
1	Liver Failure 08/2021
1	Sarcopenia 01/2021
1	Osteoporosis 01/2021
1	Phlebitis 07/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2020
1	Fibrosis (Cirrhosis) 07/2020
1	Microsatellite Instability 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 11/2023 - 08/2016
6	Rituximab (Mabthera)FDA Link 12/2023 - 05/2012
5	Antirheumatic Agents (DMARD)IBA 01/2024 - 02/2018
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2021 - 02/2012
3	Interleukin-17 (Interleukin 17)IBA 04/2024 - 07/2012
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2013
3	C-Reactive ProteinIBA 10/2023 - 07/2012
3	Immunoglobulin E (IgE)IBA 01/2022 - 01/2017
3	Abatacept (Orencia)FDA Link 11/2021 - 01/2020
3	CytokinesIBA 12/2019 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 01/2021
2	VaccinesIBA 12/2023 - 01/2023
2	ChAdOx1 nCoV-19IBA 12/2023 - 01/2023
2	Nucleic AcidsIBA 12/2023 - 01/2023
2	CreatinineIBA 12/2023 - 01/2021
2	Prednisolone (Predate)FDA LinkGeneric 10/2023 - 11/2022
2	Immunoglobulin G (IgG)IBA 01/2022 - 07/2020
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2009
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 01/2017
2	EnzymesIBA 01/2017 - 08/2016
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2014 - 01/2013
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 05/2014 - 01/2013
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024
1	Nucleic Acid-Based VaccinesIBA 12/2023
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 12/2023
1	Interleukin-9 (Interleukin 9)IBA 11/2023
1	Dual-Specificity PhosphatasesIBA 10/2023
1	pristane (pristan)IBA 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	MucinsIBA 01/2023
1	GlucocorticoidsIBA 11/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2022
1	InterferonsIBA 01/2022
1	Melanins (Melanin)IBA 01/2022
1	4'-chlorodiazepamIBA 01/2022
1	LigandsIBA 01/2022
1	golimumab FDA Link 01/2022
1	Eosinophil Cationic ProteinIBA 01/2022
1	Coe Comfort (FITT)IBA 01/2022
1	Hepatitis B Core AntigensIBA 08/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	ametantrone (HAQ)IBA 01/2021
1	AntigensIBA 10/2020
1	AutoantibodiesIBA 07/2020
1	DNA-Activated Protein KinaseIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020

Therapy/Procedure

11	Therapeutics 01/2024 - 05/2010
3	Drug Therapy (Chemotherapy) 06/2022 - 01/2015
2	Biological Therapy 01/2024 - 05/2018
2	Aftercare (After-Treatment) 01/2022 - 11/2016